For general inquiries, call 1 877-564-0008 or [email protected]. Fax PoNS device prescriptions to 1 (215) 754-4903.
What to expect with
PoNS®

Real Results

PoNSTEP Study

Participants who maintained a strong adherence to PoNS Therapy (meaning that they consistently followed their therapy plan) had a statistically significant average improvement in their DGI.

50%

of participants who maintained 85-100% adherence to PoNS Therapy saw an improvement of nearly 7 points in DGI scores

74%

of those who maintained 70% adherence gained at least a 5-point improvement in DGI scores from baseline to end of treatment

Improvement in gait function from the 14-week treatment was maintained for at least 6 months after treatment completion.

14-Week RCT to Improve Gait in MS Patients

Individuals with MS consistently using PoNS with physical therapy (PT) improved gait scores by more than >2x vs individuals with MS using a sham device and physical therapy.

Of the Active PoNS Group achieved a statistically and clinically meaningful ≥4-point improvement on the DGI just two weeks into treatment.

Mean improvement score: 7.95 by the end of PoNS Therapy

100%

Of the Placebo Group achieved a 4-point improvement on the DGI at week 10 of treatment.

Mean improvement score: 3.45 after treatment completion.

30%

Real-World Evidence Database Analysis

A database analysis of Real-World Evidence showed both clinically and statistically significant improvements in participants’ functional gait assessment (FGA) scores.

Of individuals in the study achieved a clinically meaningful 4-point improvement in their FGA

58.3%

PoNS Clinical Data Presentation

One-On-One Support

PoNS Therapy is a comprehensive, one-on-one, 14-week program guided by a PoNS Trainer for the first two
weeks of treatment before training independently at home to complete their therapy.

A Portable Treatment

PoNS is portable, which means PoNS Therapy can be completed 91% of the time at home with occasional check-ins from your PoNS Trainer.

Tailored to You

Your PoNS Therapy program will be tailored to your needs. Therapeutic activities with PoNS may include:

  • Balance training
  • Gait training
  • Breathing and awareness training
  • Other neuro-rehabilitative exercises

PoNS Therapy Application

READY TO GET STARTED?

REFERENCES:
  1. Backus, D., Langston, C., Yadav, V. J., Plummer, P., Charvet, L., Maislin, G., & Napoli, S. (2025, May). Long-term efficacy of translingual neurostimulation by a Portable Neuromodulation Stimulator on gait deficit improvement in multiple sclerosis: Results from PoNSTEP study [Conference abstract]. The Consortium of Multiple Sclerosis Centers (CMSC) Conference, Phoenix, AZ.
  2. Helius Medical, Inc. Portable Neuromodulation Stimulator (PoNS) Real-World Evidence Study August 2, 2020.
  3. Tyler ME, Kaczmarek KA, Rust KL, Subbotin AM, Skinner KL, Danilov YP. Non-invasive neuromodulation to improve gait in chronic multiple sclerosis: a randomized double-blind controlled pilot trial. J Neuroeng Rehabil. 2014;11:79. doi: 10.1186/1743-0003-11-79

Ready to get started with PoNS?

Patients who are seeking more information on how to get PoNS can email us at [email protected], or fill out our contact form:

By submitting this form, you agree to receive future updates and communication regarding the PoNS® device and other Helius products, services, programs or topics of interest. Your consent is not required as a condition of receiving any goods or services from Helius. You may choose unsubscribe and choose not to receive further information from Helius by emailing [email protected]

IMPORTANT SAFETY INFORMATION

No serious adverse events related to the PoNS device were reported in the MS RCTs or in use in clinical rehabilitation settings to treat balance and gait disorders.

Some individuals have reported headaches, fatigue, and excess salivation. Excess salivation during training sessions often occurs but generally improves as patients get used to wearing the mouthpiece.

Indication
The PoNS® device is indicated for use as a short term treatment of gait deficit due to mild to moderate symptoms from multiple sclerosis and is to be used as an adjunct to a supervised therapeutic exercise program for adults 22 years of age and over by prescription only.

Contraindications
The PoNS® device delivers electrical stimulation directly to the surface of the tongue. Precautions for use are similar to those for transcutaneous electrical nerve stimulation (TENS).

Electrical stimulation should not be used:

  • If there is an active or suspected malignant tumor
  • In areas of recent bleeding or open wounds
  • In areas that lack normal sensation

The PoNS® has not been tested on, and thus should not be used by individuals who are pregnant. Do not use the PoNS® if you are sensitive to nickel, gold or copper.

Use with caution
Electrical stimulation should only be used after seeking professional medical advice, and with caution in patients with any of the following:

  • Implanted electronic devices, including:
    • Cardiac pacemakers
    • Cardioverter defibrillators
    • Deep Brain Stimulators
    • Vagal Nerve Stimulators
    • Sacral nerve stimulators
    • Cochlear Implants
  • Metal in the mouth (e.g. piercings, braces, retainers, or other orthodontic appliance)
  • Seizure disorders
  • Epilepsy